Please login to the form below

Not currently logged in
Email:
Password:

90TEN bolsters medical education team

Agency appoints Melanie Sobczyk and Mark Lakeram

Mark and MelHealthcare communications consultancy 90TEN has appointed Melanie Sobczyk and Mark Lakeram to its medical education team following a year of growth.

Sobczyk joins the agency as an associate director from Chameleon, where she was the group account director. Her new role will see her take responsibility for the medical education client services team.

Lakeram also joins the agency as its editorial director, a newly created role which will see him lead and shape the team responsible for delivering editorial excellence across the consultancy. He is a former pharmacist and has held an associate editorial director role at Medical Knowledge Group, the medical division of Hill+Knowlton Strategies.

Alison Doughty, managing director of medical education at 90TEN, said: “Out clients come to us for our scientific expertise and strategic acumen, and both Mark and Melanie have these in spades.

“I’m delighted to be working with such a strong and talented senior team during this very exciting time for us here at 90TEN.

10th August 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics